Altium Capital Management »

Rapt Therapeutics shares owned by Altium Capital Management

Quarter-by-quarter ownership of Rapt Therapeutics shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8M 200k 8.98

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Xenon Pharmaceuticals (XENE)
Viking Therapeutics Put Put Option
Advisorshares Tr Call Call Option
Axsome Therapeutics (AXSM)
Adma Biologics (ADMA)
Alimera Sciences Com New (ALIM)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Xtant Med Hldgs Com New (XTNT)
Catalyst Pharmaceutical Partners (CPRX)
Intra Cellular Therapies (ITCI)
Biohaven (BHVN)
Viking Therapeutics (VKTX)
Olema Pharmaceuticals (OLMA)
Savara (SVRA)

View all positions for Altium Capital Management

Top funds holding Rapt Therapeutics

Group One Trading
Altium Capital Management
Simplex Trading

View all funds holding Rapt Therapeutics